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Purpose: To evaluate, in a group of technically high-risk patients, the results of infrain- 
guinal revascularization using a conduit construeted with endarterectomized superficial 
femoral artery (SFA) and available arm or saphenous vein. 
Methods: Of 237 consecutive lower extremity vein graft bypass procedures performed in 
195 patients from July 1992 through August 1996, 15 SFA eversion endarterectomies 
(in 10 men and five women; median age, 70 years) were performed and used as a 
composite bypass conduit with available autogenous rein for the treatment of limb- 
threatening ischemia. In each case, an occluded SFA was divided 8 to 15 cm distal to its 
origin, proximally endarterectomized, and sewn end-to-end to a segment of veän to 
provide adequate conduit length for bypass grafting. Indications for this technique were 
unavailability of vein as a result of failed previous bypass grafting (n = 10) or previous 
coronary artery bypass grafting (n = 5). Veins were sewn distally to a below-knee 
popliteal artery (n = 4; 27%) or tibial artery (n = 11; 73%). 
Results: Primary patency, secondary patency, and limb salvage rates at 36 months by life 
table analyses for the 237 grafts were 62.3%, 81.0%, and 77.2%, respectively. The 15 
composite SFA-vein bypass grafts had 36-month primary patency, secondary patency, 
and limb salvage rates of 60.0%, 72.0%, and 65.9%, respectively (mean follow-up, 15 
months). Currently, eight of these patients (53%) have patent bypass grafts; two (13%) 
died at 4 and 18 months after the operation with patent grafts; two (13%) underwent 
amputations for progressive foot gangrene despite apatent bypass graft; and three (20%) 
had grafts that thrombosed at 4, 5, and 10 months. Typical hyperplastic intIinsic 
graft-threatening stenoses developed in two patients (13%) in the SFA segment at 4 and 8 
months; they were discovered by routine duplex scan surveillance. 
Conclusion: Composite SFA eversion endartereetomy/vein graft conduits yield acceptable 
results, behave similarly to other autogenous condtfits used for technically high-risk 
infrainguinal revascularization, and are beneficial when autogenous vein is limited. 
(J Vasc Surg 1997;26:439-46.) 
Bypass grafting with greater saphenous vein has 
emerged as the most durable method of treatment 
for lower extremity ischemia in patients who have 
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femoropopliteal rterial occlusive disease. Problems, 
therefore, arise when greater saphenous rein is un- 
available, especially when the bypass graft is to an 
infrageniculate artery. Methods of attaining ade- 
quate bypass length include originating the graft 
from an alternative arterial inflow source, specifically, 
a nondiseased superficial femoral, deep femoral, or 
popliteal artery, and harvesting an alternative con- 
duit. Alternative conduits to r_he ipsilateral greater 
saphcnous vein include contralateral greater saphe- 
nous vein, lesser saphenous vein, basilic and cephalic 
arm vein, composite grafts using segments of pros- 
thetic material attached to available vein, and ex- 
panded polytetrafluoroethylene (ePTFE) grafts with 
or without a distal anastomotic vein patch or arterio- 
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Big. 1. A, Superficial femoral artery divided distally, with eversion endarterectomy in progress. 
B, Endarterectomized femoral artery is then sewn to a segment ofautogenous vein, end-to-end, 
to construct a conduit for distal bypass. 
venous fistula. Although some controversy remains, 
the limitations of prosthetic material and infraingui- 
nal revascularization are well documented, 1 prompt- 
ing many to advocate an all-autogenous bypass con- 
duit policy whenever possible? 
To this end, we have used a composite conduit 
constructed with available autogenous vein sewn to a 
segment of endarterectomized superficial femoral ar- 
tery, prepared by the eversion endarterectomy 
method, in situations in which most autogenous vein 
has previously been harvested. Although this proce- 
dure has been reported anecdotally, 3 few objective 
data exist on these conduits used as bypass grafts. 
This report therefore reviews our experience in a 
group of high-risk patients with superficial femoral 
artery eversion endarterectomy used as a composite 
graft with autogenous vein for infrainguinal revascu- 
larization. 
METHODS 
From July 1992 until September 1996, 253 con- 
secutive infrainguinal revascularization procedures 
were performed in 212 patients and were managed 
on the vascular surgery service at Greenville Memo- 
rial Hospital. In an effort to maintain the policy of 
autogcnous vascular econstruction whenever possi- 
ble, 237 of the 253 grafts were constructed with 
autogenous venous conduits, and 16 were con- 
structed with ePTFE. Of these 237 grafts, 229 were 
reversed vein bypass grafts, and eight were performed 
using the in situ technique. Two hundred twenty 
(92%) were performed because of severe limb-threat- 
ening ischemic rest pain or tissue loss. One hundred 
fifty grafts (63%) were anastomosed distally to a tibial 
or pedal vessel, whereas 87 (37%) were anastomosed 
to the popliteal artery. 
In 15 patients in whom autogenous vein was 
extremely limited, a bypass conduit was constructed 
using available greater saphenous, lesser saphenous, 
or arm vein sewn to a proximal segment ofendarter- 
ectomized superficial femoral artery prepared by 
eversion endarterectomy, as shown in Fig. 1. In each 
patient, asegment of chronically occluded superficial 
femoral artery was mobilized, depending on the total 
length of conduit needed and the length of the 
available vein harvested. The artery was divided dis- 
tally, endarterectomized, and sewn end-to-end to 
the vein. Any size discrepancy between a larger fern- 
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oral artery and a smaller vein segment was corrected 
by bevelling the ends before anastomosis. The anas- 
tomosis also incorporated an adjacent venous side 
branch, when possible, to minimize an abrupt diam- 
eter difference in the composite conduit. The con- 
duit was then tunneled and anastomosed to the 
appropriate distal outflow artery. The superficial fem- 
oral endarterectomy was performed using the ever- 
sion endarterectomy technique described by Ina- 
hara, 4 with care in removing all intimal as weil as 
circular medial muscular fibers from the vessel wall. 
The length of the superficial femoral artery, mobi- 
lized and everted, ranged from 8 to 15 cm (median, 
12 cm; mean, 11.6 cm), depending on the length of 
the available vein. In seven instances (46%) a proxi- 
mal arteriotomy was made at the common femoral 
artery near its bifurcation to assist with the proximal 
intimal dissection and to make sure that the profunda 
femoris artery orifice remained patent. These arteri- 
otomies were either closed primarily (two patients) 
or patched (Dacron, four patients; vein, orte patient) 
before performance of the bypass procedure. Patch 
angioplasty was usually used when concomitant pro- 
fundoplasty or common femoral endarterectomy was 
necessary. 
These superficial femoral artery/vein graft con- 
duits were placed in 10 men and five women, with a 
median age of 70 years (range, 46 to 79 years). 
Fourteen of the 15 patients were cigarette smokers 
(present or former), and eight had diabetes. 
The indication for bypass grafting was limb- 
threatening ischemia in all 15 patients, with fissue 
loss present in four patients. Ten patients (66%) had 
undergone previous infrainguinal vascular recon- 
struction, and four of these pätients had undergone 
two prior reconstruction procedures. Five (33%) had 
undergone previous coronary artery bypass grafting. 
Thus in all 15 cases autogenous rein was limited. In 
addition, proximal or diffuse atherosclerosis prohib- 
ited the use of an alternative arterial inflow source, 
such as the deep femoral artery, to provide the 
needed length for the bypass graft. As weil, in most 
of the 15 cases, the conduit length discrepancy was 
greater than what could be achieved by originating 
the graft from the distal profunda. In general, there- 
lore, the constructed superficial femoral endarterec- 
tomy-vein graft conduit was considered a "last- 
ditch" autogenous effort. In no instance was the 
procedure attempted and abandoned. 
M1 bypass grafts were sewn distally below the 
knee, with four grafts (26%) anastomosed to the 
below-knee popliteal artery and 11 grafts (73%) anas- 
tomosed to a tibial or pedal vessel. The only available 
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Fig. 2. Life table analysis of primary and secondary pa- 
tency data and limb salvage data for the entire series (237 
procedures). 
vein for bypass grafting was a short piece of greater 
saphenous vein (11 patients, 73%), composite spliced 
basilic vein (one patient, 6%), composite spliced ce- 
phalic vein (one paUent, 6%), lesser saphenous vein 
(one paUent, 6%), or composite spliced lesser saphe- 
nous and greater saphenous rein (orte patient, 6%). 
All of these venous grafts were reversed before at- 
tachment to the distal superficial femoral artery. 
Our general operative technique for infrainguinal 
revascularization a d prospective follow-up proto- 
cols have been previously described. 5 Each patient 
with a bypass graft underwent comprehensive duplex 
scan surveillance and ankle-brachial index (ABI) 
measurement every 3 months for the first 18 months 
and then every 6 months thereafter. Abnormaliues 
that suggested a failing graft were investigated fur- 
ther by arteriography. 
Primary and secondary graft patency rates and 
limb salvage rates were calculated using standard life 
table analysis. 
RESULTS 
Follow-up (evaluation within 3 months of the 
study period) was complete for all patients in the 
series. Life table analyses for primary and secondary 
patency data, as weil as limb salvage data, are shown 
graphically in Fig. 2. The early operative (30-day) 
mortality rate was 5.1%. At 36 months, the primary 
patency rate was 62.3%, the secondary patency rate 
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Fig. 3. Life table analysis of primary and secondary pa- 
tency data and limb salvage data for composite superficial 
femoral artery eversion endarterectomy/vein co duit by- 
pass grafts (15 patients). 
was 81.0%, and the limb salvage rate was 77.2%. A 
total of 27 grafts (11.3%) were revised after duplex 
scan surveillance detected graft-threatening prob- 
lems. 
Primary patency, secondary patency, and limb 
salvage rates for the 15 composite superficial femoral 
artery/vein conduit bypass grafts are shown in Fig. 3. 
There were no operative deaths in this group of 
patients. Likewise, there were no early (30-day) car- 
diac or pulmonary complications. There were two 
minor wonnd infections that responded to antibiot- 
ics and one lymph leak in another patient hat led to 
longer hospitalization but resolved with bed rest. 
Postoperative edema was present in varying degrecs 
in all patients, but it was not thought o be unusually 
excessive in any and eventually resolved in all healed 
extremities. 
Before the operation, ABIs in the 15 threatened 
extremities ranged from 0 to 0.47 (median, 0.37; 
mean, 0.24). Three extremitics had no Doppler sig- 
nal on presentation, and two had medial calcific vas- 
cular diseasc on presentation; in the latter, no AB1 
was obtainable. These two patients had toe prcssures 
of 0 and 20 mm Hg. After the operation, ABIs 
ranged from 0.63 to 1.08 (median, 0.87; mean, 
0.72). Improvement in ABI occurred in each patient 
and ranged from 0.2 to 0.93 (median, 0.56; mean, 
0.53). In the two patients from whom ABIs could 
not be obtained, toe pressures improved from 0 mm 
Hg to 70 mm Hg and from 20 mm Hg to 70 mm 
Hg. 
Follow-up for the 15 study patients ranged from 
1 to 42 months (mean, 14.5 months). Eight patients 
(53%) are still alive with patent grafts and healed 
exn'emities. Two patients (13%) died with patent 
bypass grafts at 4 months (intracerebral hemorrhage) 
and 18 months (congestive heart failure). Despite 
functioning, patent bypass grafts with improved he- 
modynamics, two patients had distal foot ulceration 
that did not heal This failure to heal was probably a
result of infection and poor distal runoff in the foot, 
which eventually necessitated major limb amputation 
at 1 and 4 months after the operation. 
Three grafts thrombosed at 4 months, 5 months, 
and 10 months. The cause of graft thrombosis was 
uncertain in one patient. A review of his last graft 
flow velocity obtained at 3 months howed adiffusely 
large conduit (including the superficial femoral arte- 
rial segment) with a flow of 40 cm/sec and a distal 
anastomotic flow of 239 cm/sec. Despite systemic 
anticoagulation, this graft thrombosed at 5 months. 
The patient underwent repeat bypass grafting with 
spliced arm vein; the limb was salvaged. The other 
two patients had known, severe, unreconstructable 
distal tibial and pedal disease that, despite anticoagu- 
lation, was thought o be the cause of graft failure. 
Both patients required through-lmee and above- 
knee amputations. 
Intrinsic stenoses developed in two patients' end- 
arterectomized superficial femoral artery segments 
(13.3%) at 3 months and 8 months after surgery. A 
focal stenosis in one artery lowered the distal graft 
flow velocities to less than 45 cm/sec. This lesion 
was confirmed with arteriography and was treated 
with percutaneous transluminal angioplasty. The le- 
sion recurred at 4 months and eventually required 
patch angioplasty..The patient with the second arte- 
rial intrinsic stenosis had a diffuse narrowing along 
the entire endarterectomized arterial segment and 
was treated with patch angioplasty. Both lesions ap- 
peared hyperplastic n nature. One patient's bypass 
graft is secondarily patent 12 months after his origi- 
nal surgery, and the other patient eventually lost her 
leg, despite apatent bypass graft, 4 months after her 
original surgery. In each case, the superficial femoral 
diameter was of adequate size. One of the artery 
segments was 14 cm in length (focal stenosis), and 
the other was 12 cm (diffuse stenosis). 
At least wo graft flow velocities were obtained (1 
and 3 months after operation) in each of the 15 study 
patients with grafts. In four patients (27%) an in- 
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creased-diameter superficial femoral artery segment 
could be identified with focally low (<45 cm/sec) 
graft flow velocities. Flow velocities normalized in 
the smaller-diameter v ins attached below the arterial 
segments in each case. Interestingly, a normal flow 
velocity developed in one of these low-flow arterial 
segments over the time between the two scans. A 
hyperplastic stenosis occurred in one of the arterial 
segments with this arterial-venous flow mismatch. 
Ten of the remaining conduits had normal graft flow 
velocities, making the transition from artery to vein 
difficult to discern. The remaining conduit had dif- 
fuse low flow and eventually failed despite anUcoag- 
ulation. 
Eleven extremities were salvaged in these 15 pa- 
Uents during the study period. Thus, for the conduits 
constructed with a segment of endarterectomized 
superficial femoral artery spliced to a piece of autog- 
enous vein, the 36-month primary patency rate was 
60.0%, the secondary patency rate was 72.0%, and 
the limb salvage rate was 65.9%. 
As a comparison, two other high-risk bypass 
groups were analyzed from our data. Figs. 4 and 5 
show life table graphs of these t-wo groups--bypass 
grafts that were constructed after an initial bypass 
procedure had failed (redo bypass grafts) and all 
bypass grafts that were constructed with autogenous 
arm ~ein. The patency and limb salvage rates in these 
groups were comparable with those in the superficial 
femoral artery/vein conduit group. Log-rank statis- 
tical analysis for the comparison of two survival 
curves indicated no statistically significant difference 
in the secondary patency rate between the endarter- 
ectomized superficial femoral/vein conduit group 
and either the arm vein group (72.0% vs 69.6%; p = 
0.95), the redo group (72.0% vs 79.7%; p = 0.74), or 
the entire group (72.0% vs 81.0%; p = 0.37) of 
bypass grafts. 
DISCUSSION 
The techniqne of eversion endarterectomy for 
thc treatmcnt oflower extremity ischemia isnot new. 
Probably first performed on the iliac artery and re- 
ported in 1965 by Inahara, 6 eversion endarterectomy 
quickly became auseful tool in the vascular surgeon's 
armamentarinm. Superficial femoral artery eversion 
endarterectomy was first described in 1967 by Harri- 
son et al.3 as "a procedure patterned after the old- 
time rural method ofpreparing sausage casings from 
hog intestines." Despite early enthusiasm for the 
operation, its limitations as a definitive procedure 
surfaced as unacceptably high restenosis rates devel- 
oped. It was believed at the timc that the superficial 
femoral arterial diameter might be too small for 
long-term patency when treated by eversion endar- 
terectomy alone and that the eversion technique it- 
self might damage the vesscl wall. 7 
Interest in superficial femoral endarterectomy as a
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definitive procedure to treat chronic lower extremity 
ischemia was rekindled in the 1980s by OurM et al.,8 
when they reported a 66% 3-year patency rate in 
selected patients with segmental stenoses of the sn- 
perficial femoral artery at the adductor canal. This 
interest waned, however, in the late 1980s with the 
emergence of the supeilor results reported for in- 
frainguinal bypass grafting coupled with close duplex 
scan surveillance. Our report, however, reemphasizes 
the importance ofsuperficial femoral artery endarter- 
ectomy and suggests it may play a new, adjunctive 
role with current bypass grafting techniques. Our 
choke of using the evcrsion method as opposed to 
the open or semiclosed method was arbitrary. The 
eversion method is easy and can produc e a tubular 
conduit that can be tunnelcd like a standard vein 
graft after one end-to-end anastomosis to a vein. 
Currently, few data exist regarding the perfor- 
mance of this conduit when it is used as an infrain- 
guinal bypass graft. Through the use of this tech- 
nique, this seiles of high-ilsk patients, two-thirds of 
whom were undergoing their second or third bypass 
procedure, attaincd an acceptable secondary graft 
patency rate of 72.0% and a limb salvage rate of 
65.9% at 3 years. In fact, there was actually no statis- 
tically significant difference in cumulative secondary 
patency rates among grafts constructed with endar- 
terectomized superficial femoral artery/vein con- 
duits and in those of the entire seiles. However, small 
numbers of patients mean that only relatively large 
differences would be detectable between the t-wo 
groups. 
This study raises the provocative question of 
when one should use a supcrficial femoral eversion 
endarterectomy in conjunction with a rein graft for 
infrainguinal revascularization. We have enthusiasti- 
cally adopted the philosophy of using alternative ar- 
terial inflow sources when adequate venous length is 
a problem. We have published our experience with 
the use of the deep femoral artery as an inflow source 
and advocate its use when it is free ofdisease and is of 
good quality. 9Likcwise, 44 of the 237 grafts (19%) 
in this seiles originated from a popliteal or tibial 
artery and have performed weil (36-month second- 
ary patency rate of 89% by life table analysis). We 
continue to use these methods preferentially to su- 
pefficial femoral eversion endarterectomy when pos- 
sible. In contrast, we have been disappointed with 
ePTFE when it is used as a bypass graft to a tibial or 
pedal vèssel. Although our expeilence is limited, dur- 
ing the study period we constructed six bypass grafts 
with ePTFE from the femoral artery to a tibial vessel 
for limb salvage--two with distal anastomotic vcin 
patches and two with distal arteriovenous fistulas. 
Five grafts have thrombosed from 1 to 10 months 
after surgery, and only one remains patent at 1 
month. Disappointingly, only two limbs have been 
salvaged by this technique. We believe, therefore, 
t_hat he superficial femoral eversion endarterectomy- 
vein graft conduit provides an additional autogenous 
option for infrainguinal bypass grafting and advocate 
its use over that ofePTFE--especially when grafting 
to a tibial artery. 
One final observation from these data stresses the 
continued importance of routine graft surveillance by 
duplex scanning--even atthe portion of endarterec- 
tomized superficial femoral artery. For the entire 
seiles of bypass grafts, the incidence of intrinsic graft 
stenosis that required operative intervention was 
11.3%. The incidencc of hyperplastic stenotic lesions 
occurring in the arterial portion ofour 15 superficial 
femoral artery/vein bypass conduits was a similar 
13.3%, suggesting a congruent propensity of these 
arteilal segments to develop graft-threatening le-
sions. On the basis of these findings, we recommend 
routine duplex scan surveillance of the endarterecto- 
mized artery, as weil as of the vein. Devclopment of 
intrinsic graft-thrcatening lesions appeared to be in- 
dependent of artery diameter or length of superficial 
femoral artery segment endarterectomized. Until the 
cause ofneointimal hyperplasia can be elucidated and 
prevented, routine surveillance remains the best de- 
fense against graft thrombosis. 
CONCLUSION 
Composite superficial femoral artery eversion 
endarterectomy/vein graft conduits yield results 
similar to those with other autogenous conduits, may 
develop intrinsic graft stenoses at rates similar to 
those of other conduits, and area beneficial alterna- 
tive when adequate autogenous vein is unavailable. 
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DISCUSSION 
Dr. James A. DeWeese (Rochester, N.Y.). I have 
enjoyed Dr. Taylor's presentation and I also appreciated 
having the opportunity to read the paper. Before or during 
the performance of 237 lower extremity vein bypass graft- 
ing procedures, Dr. Taylor and his associates discovered on 
15 occasions that there was not an adequate rein of suffi- 
cient length to perform the proposed operation. On these 
patients, they performed an eversion endarterectomy of 10 
to 12 cm length, and then performed bypass grafting 
distally. Primary patency rates of 62% and secondary pa- 
tency rates 9f 81% at 3 years were achieved. I would ver,/ 
rauch like to compliment them on their persistence in 
using autogenous materials for their arterial reconstruc- 
tions in these 15 pätients. As they have stated, the use of a 
proximal femoral endarterectomy to accomplish this is not 
new, Actually, in 19ö4 we reported the use ofa semiclosed 
or open thromboendarterectomy as an inflow for a distal 
vein bypass graft in five extremities. Inahara nd I am sure 
many other of the older surgeons here at least have used 
this through the years. In 1967, Harrison reported per- 
forming 25 eversion lower extremity endarterectomy pro- 
cedures, of which three were performed for this specific 
reason. Dr. Taylor's favorable xperience with the com- 
bined operation shoutd again alert all vascular surgeons 
that there is an alternative to the use of a long prosthetic 
graft in some patients with a limited amount ofvein. There 
may be some question about the best technique for per- 
forrning the femoral endarterectomy. When Dr. Harrison 
reported his 25 eversion endarterectomy cases in 1967, 
Wylie Barker in his discussion expressed concern that the 
added trauma of doing it as an eversion might contribute 
to atheromatous scarring and earlier graft occlusions. In- 
deed, Dr. Harrison, in I968, while discussing a paper of 
John Connolly's concerning eversion endarterectomy re-
ported the early development of a thickened endoluminal 
lining in seven of 25 eversion endarterectomy procedures 
that he had performed. Now, in addition, the patency rate 
of short thromboendarterectomy less than 15 cm using 
either open or semiclosed techniques reported by Dr. Ina- 
hara and also ourselves is similar to that reported by Dr. 
Taylor, räising the question of whether the eversion 
method really has any advantages over standard methods. 
My only question of Dr. Taylor would be whether he 
noticed that the femoral endarterectomy segment of the 
reconstruction actually did show stenosis during follow- 
up. 
Once again, I would like to thank Dr. Taylor for 
bringing to our attention the advantages of endarterec- 
tomy and vein graft when the available veins are oflimited 
length. 
Dr. Spence M. Taylor. Thank you, Dr. DeWeese, for 
those comments. We have very little experience with any 
other method of endarterectomy used in this particular 
way. We prefer the eversion method simply because you 
can make a nice conduit and you can tunnel it similarly as a 
vein graft. They basically function just like a femoropopli- 
teal bypass graft without having to do the proximal anasto- 
mosis, if you will. So, it tunnels weil, and these are out 
results. We have no other comparison i  terms of different 
types of techniques of endarterectomy to compare it with. 
Dr. J. Haro ld  Harr ison (Atlanta, Ga.). I reported the 
eversion endarterectomy of iliac and femoral arteries as has 
been said in 1967, some 25 cases. From the late 1950s up 
until the early 1970s, we used endarterectomy as a primary 
treatment ofocclusive disease almost exclusively. The ever- 
sion endarterectomy was by and rar the best-looldng oper- 
ation that I had ever seen. We were very excited about 
presenting it, but then Wylie Barker got up and made the 
profound statement that accelerated atherogenesis from 
the extra trauma probably was going to get us in trouble, 
which it did. Other folks thought hat this was going to be 
a world-shaking operation, and beßore the water gor warm, 
by the next year, another series had been reported and I 
had to get up and tell them what was happening. Wylie 
Barker was very accurate. We were getting into more trou- 
ble apparently from the accelerated atherogenesis. We ob- 
viously slowed down the use of this procedure. I have 
continued, however, to use it in short segments of arteries 
along the way, and we are encouraged that someone is 
taking it back, because as we learn more about he methods 
of preventing the disease, and with some of the other 
techniques, it may come back to the point where it will 
function. Until that point, we are basically in trouble. 
One thing that we pointed out at the t ime-- I  went 
back and read the papers--a great deal of tissue reaction 
occurs around an endarterectomized artery with eversion. 
This makes going back in for further procedures very 
difficult. We are leery of using vein in association with an 
endarterectomy. If you are going to use an endarterec- 
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tomy, use the endarterectomy all the way and save your 
rein for what yon have for later use. 
Dr. Taylor. I appreciate your comments, and I hope 
we don't have to come back and rebut hext year with these 
all failed. We will continue to prospectively observe them, 
obviously. We are 36 months out and we will keep an eye 
on them for sure. 
Dr. Robert W. Barnes (Gainesville, Fla.). I would just 
like to suggest a technical modification that facilitates re- 
moval of all of the medical fibers that, as in the carotid 
system, may reduce the incidence of recurrent stenosis. 
The eversion method of endarterectômy provides good 
visualization ofonly the distal portion of the conduit hat is 
turned inside out. Instead of doing an eversion, why not 
perform an "inversion" endarterectomy through a proxi- 
mal longitudinal incision over the distal common femoral 
artery extending over the orifice of the superficial femoral 
artery? After developing the endarterectomy plane around 
the proximal end of the plaque, the entire superficial fem- 
oral artery can be inverted by tractäon of the plaque. You 
can then remove completely those medial fibers under 
direct vision. In my own experience , this has reduced the 
incidence ofrecurrent stenosis, although I perform endar- 
terectomy very selectively in patients, just as you do. 
Dr. Taylor. I appreciate the comments. 
Dr. John A. Mannick (Boston, Mass.). Just a final 
word about the durability of these procedures. As many 
other surgeons have done, we have used endarterectomy, 
in our case open and under direct vision, without eversion, 
as a way ofgetting down the leg to start a bypass vein graft. 
We have found this to be quite a satisfactory procedure. 
One of the things that has been most gratifying about it in 
our hands is that, as opposed to plastic prostheses, endar- 
terectomy stenoses, like vein graft stenoses, occur early. If  
the endarterectomized s gment isin a good shape at about 
12 months, you can be quite confident hat it is going to 
stay that way for a very long period of time. I do think that 
is a signal advantage. I wonder whether your observations 
have been the same. I was not quite sure about that from 
your presentation. 
Dr. Taylor. Our observations were exactly the same. 
They tend to function and look just like vein grafts, in 
terms of intrinsic rein graft stenoses. The t-wo areas that 
stenosis occurred, one at 3 months and one at 5 months, 
were early hyperplastic lesions, and all this suggests that 
duplex scan surveillance should be carried through to these 
segments as weil. 
Dr. Michael D. Kropilak (Knoxville, Tenn.). I fyou 
have a good profunda, would you prefer the profunda for 
inflow over endarterectomized superficial femoral artery? It 
seems like you are not gaining that much length with an 
endarterectomized superficial femoral artery, if they are 10 
to 12 cm. 
Dr. Taylor. Joe Mills and I reported using the pro- 
funda as an inflow source and have been very pleased with 
this, but you can get even a longer segment of superficial 
femoral artery. We have gone as far as 15 cm, which is 
longer than one could achieve with the profunda. 
